NatureGeneticsPeer-reviewed journal article
Common genetic variants contribute to risk of rare severe neurodevelopmental disorders
Mari NiemiiD, Hilary C. MartiniD, Daniel L RiceiD, Giuseppe GalloneiD, Scott D. GordoniD, Martin KelemeniD, Kerrie McAloneyiD, Jeremy F. McRaeiD, Elizabeth J. RadfordiD, Sui YuiD, Jozef GécziD, Nicholas G. MartiniD, Caroline Fiona WrightiD, David R FitzPatrickiD, Helen V. FirthiD, Matthew E. HurlesiD, Jeffrey C. BarrettiD
Abstract
There are thousands of rare human disorders caused by a single deleterious, protein-coding genetic variant 1. However, patients with the same genetic defect can have different clinical presentation 2-4, and some individuals carrying known disease-causing variants can appear unaffected 5. What explains these differences? Here, we show in a cohort of 6,987 children with heterogeneous severe neurodevelopmental disorders expected to be almost entirely monogenic that 7.7% of variance in risk is attributable to inherited common genetic variation. We replicated this genome wide common variant burden by showing that it is over-transmitted from parents to children in an independent sample of 728 trios from the same cohort. Our common variant signal is significantly positively correlated with genetic predisposition to fewer years of schooling, decreased intelligence, and risk of schizophrenia. We found that common variant risk was not significantly different between individuals with and without a known protein-coding diagnostic variant, suggesting that common variant risk is not confined to patients without a monogenic diagnosis. In addition, previously published common variant scores for autism, height, birth weight, and intracranial volume were all correlated with those traits within our cohort, suggesting that phenotypic expression in individuals with monogenic disorders is affected by the same variants as the general population. Our results demonstrate that common genetic variation affects both overall risk and clinical presentation in disorders typically considered to be monogenic.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 340
- FWCI
- 21.62
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dissecting the contribution of common variants to risk of rare neurodevelopmental conditions
Qin Qin Huang, Emilie M. Wigdor, … Hilary C. Martin·medRxiv·Mar 5, 2024
- Substantial role of rare inherited variation in individuals with developmental disorders
Kaitlin E. Samocha, V. Kartik Chundru, … Matthew E. Hurles·medRxiv·Aug 28, 2024
- Assortative mating and parental genetic relatedness drive the pathogenicity of variably expressive variants
Corrine Smolen, Matthew Jensen, … Santhosh Girirajan·medRxiv·May 18, 2023
- Rare schizophrenia risk variants are enriched in genes shared with neurodevelopmental disorders
Tarjinder Singh, James T. R. Walters, … Jeffrey C. Barrett·bioRxiv·Aug 16, 2016
- Rare genetic variants in dominant developmental disorder loci cause milder related phenotypes in the general population
Rebecca Kingdom, Marcus A. Tuke, … Caroline Fiona Wright·The American Journal of Human GeneticsPeer-reviewed·Jun 13, 2022
- Genetic modifiers of rare variants in monogenic developmental disorder loci
Rebecca Kingdom, Robin N. Beaumont, … Caroline Fiona Wright·Nature GeneticsPeer-reviewed·Apr 18, 2024